A Genome-Wide Association Study (GWAS) Of Survival In Metastatic Breast Cancer (MBC) Patients Treated With Letrozole (L) With Or Without Bevacizumab (B) In CALGB 40503 (Alliance)
- Citation:
- J Clin Oncol vol 34 (suppl) abstr 538
- Meeting Instance:
- ASCO 2016
- Year:
- 2016
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3232
- Pharmas:
- Genentech
- Grants:
- U10CA031946, U10CA033601, U10CA180821, U10CA180882, U10CA138561, U10CA180791, U10CA180795, U10CA180820, U10CA180838, U10CA180858, U10CA180867, U10CA180888, P30 CA008748
- Corr. Author:
- Federico Innocenti
- Authors:
- Federico Innocenti Kouros Owzar Chen Jiang Alexander B Sibley Flora Mulkey Lisa Carey Debu Tripathy Bryan Schneider William T Barry Eric P Winer Clifford A Hudis Howard L McLeod Maura N Dickler
- Networks:
- LAPS-CT018, LAPS-NC007, LAPS-NY016, LAPS-TX035, NY018
- Study
- CALGB-40503
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: